Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank

Fig. 4

Incurred gross cost–budgeted cost. a: Comparative analysis between investments of Spanish HIV HGM BioBank’s capital versus volume of recovery budgeted. Budgeted cost–granted cost. b Negotiation success in signing the Spanish HIV HGM BioBank’s budgets. Deviations in this stage entail a need for increase the investment of own capital thus economic viability of the project and Spanish HIV HGM BioBank can be compromised

Back to article page